Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on: October 03,2025 0

Ivonescimab + chemotherapy improves progression-free survival in patients with EGFR+ NSCLC

Updated on:October 03,2025 0

Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration

Updated on: October 02,2025 0

Inhibiting an astrocytic 'brake' that blocks spinal cord repair could pave path to neuronal regeneration

Updated on:October 02,2025 0

Scientists identify novel therapeutic target for ovarian cancer

Updated on: October 02,2025 0

Scientists identify novel therapeutic target for ovarian cancer

Updated on:October 02,2025 0

Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals

Updated on: October 02,2025 0

Misconceptions keep some cancer patient populations from benefiting from hormone therapy, survey reveals

Updated on:October 02,2025 0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on: October 02,2025 0

Nivolumab maintains quality of life and reduces symptom deterioration in resectable NSCLC, trial shows

Updated on:October 02,2025 0

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Updated on: October 02,2025 0

BMS-986504 demonstrates durable responses in MTAP-deleted NSCLC, including EGFR and ALK-positive tumors

Updated on:October 02,2025 0

Smoking status should influence lung cancer staging, new study shows

Updated on: October 02,2025 0

Smoking status should influence lung cancer staging, new study shows

Updated on:October 02,2025 0

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Updated on: October 02,2025 0

Lung cancer rewires immune cells in bone marrow to weaken body's defenses

Updated on:October 02,2025 0

GLP-1 receptor agonists may improve lung cancer outcomes

Updated on: October 02,2025 0

GLP-1 receptor agonists may improve lung cancer outcomes

Updated on:October 02,2025 0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on: October 02,2025 0

New research identifies IFITM3 as key driver of immunotherapy response in small cell lung cancer

Updated on:October 02,2025 0